[A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)].

MLA

Wada, Atsushi, et al. “[A Favorable Clinical Course of Acute Myeloid Leukemia with t (6;21;8)(P23;Q22;Q22)].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, vol. 63, no. 2, 2022, pp. 104–07. EBSCOhost, https://doi.org/10.11406/rinketsu.63.104.

APA

Wada, A., Doki, N., Otsuka, Y., Adachi, H., Konuma, R., Kishida, Y., Konishi, T., Yamada, Y., Nagata, A., Nagata, R., Marumo, A., Noguchi, Y., Mukae, J., Toya, T., Igarashi, A., Najima, Y., Kobayashi, T., Harada, H., Harada, Y., … Ohashi, K. (2022). [A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)]. [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, 63(2), 104–107. https://doi.org/10.11406/rinketsu.63.104

Chicago

Wada, Atsushi, Noriko Doki, Yuki Otsuka, Hiroto Adachi, Ryosuke Konuma, Yuya Kishida, Tatsuya Konishi, et al. 2022. “[A Favorable Clinical Course of Acute Myeloid Leukemia with t (6;21;8)(P23;Q22;Q22)].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology 63 (2): 104–7. doi:10.11406/rinketsu.63.104.